Odyssey Announces Agreement to Combine with BenevolentAI

BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective medicines Combination of BenevolentAI with Odyssey, a €300m Euronext Amsterdam-listed special purpose acquisition company focused on European healthcare and technology, represents the largest European SPAC merger to […]

thaipr.net

7 ธ.ค. 64

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results

RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation, opaganib and RHB-107’s unique host-targeted mechanisms of action hold potential versus Omicron and other variants – Phase 2/3 study sub-population analysis demonstrated a 62% reduction in mortality in moderately severe hospitalized patients; Data packages […]

thaipr.net

3 ธ.ค. 64

Sai Life Sciences’ pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that the Japanese regulatory agency, Pharmaceuticals and Medical Devices Agency (PMDA) completed a paper-based compliance inspection of its intermediate & API manufacturing facility in Bidar, India and issued a Certificate of Inspection. Previously, the agency had conducted a three-day long physical audit in…

thaipr.net

2 ธ.ค. 64

GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan, today announces a strategic agreement for joint research and development project on GenScript’s cPass™ SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit as the in vitro neutralization assay of a BC-PIV derived SARS-Cov-2 […]

thaipr.net

1 ธ.ค. 64

Róbert Wessman-led Aztiq and Innobic join forces in $475m acquisition of Lotus Pharmaceutical and Adalvo to create a global pharmaceutical powerhouse

– The Aztiq-Innobic consortium will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceutical and the sole shareholder in Adalvo – Róbert Wessman, chairman and CEO of Alvogen and founder of Aztiq, will continue as chairman of the board of Lotus and Adalvo. – The consortium creates a unique alliance of […]

thaipr.net

26 พ.ย. 64

Global COVID-19 Safety Innovator Expands Its Offerings

“Investing smartly in the safety of employees.” Including, now, a US OSHA COVID-Rules-Compliant SaaS Platform Enhancement Safely2Prosperity LLC CEO John Norris, JD, MBA, announces S2P’s new COVID-19 Safety Platform and Employee Dashboard for quick demonstration and immediate deployment. Together with add-ons, they give employers the world’s first comprehensive COVID Safety Program. The further enhanced COVID Safety…

thaipr.net

24 พ.ย. 64
1 87 88 89 90 91 128